HOME
Lung Cancer Awareness Month
Day:
May 22, 2016
Fas Ligand Based Immunotherapy: A Potent and Effective Neoadjuvant with Checkpoint Inhibitor Properties, or a Systemically Toxic Promoter of Tumor Growth?
×